BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1457860)

  • 21. Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.
    Curtis AB; Cannom DS; Bigger JT; DiMarco JP; Estes NA; Steinman RC; Parides MK
    Am Heart J; 1997 Nov; 134(5 Pt 1):787-98. PubMed ID: 9398090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myocardial revascularization may resolve arrhythmic warm-up in patients with implantable cardioverter-defibrillator: 2 case reports].
    Paffoni P; Bortnik M; Pedrigi C; Perucca A; Occhetta E; Vassanelli C
    Ital Heart J Suppl; 2000 Dec; 1(12):1591-6. PubMed ID: 11221589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and benefit of additional aortocoronary bypass grafting in patients undergoing cardioverter-defibrillator implantation.
    Trappe HJ; Klein H; Wahlers T; Fieguth HG; Wenzlaff P; Kielblock B; Lichtlen PR
    Am Heart J; 1994 Jan; 127(1):75-82. PubMed ID: 8273759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.
    Mittal S; Iwai S; Stein KM; Markowitz SM; Slotwiner DJ; Lerman BB
    J Am Coll Cardiol; 1999 Oct; 34(4):1082-9. PubMed ID: 10520794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
    Raja V; Wiegn P; Obel O; Christakopoulos G; Christopoulos G; Rangan BV; Roesle M; Abdullah SM; Luna M; Addo T; Ayers C; Garcia S; de Lemos JA; Banerjee S; Brilakis ES
    Am J Cardiol; 2015 Nov; 116(9):1358-62. PubMed ID: 26341182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias.
    Crandall BG; Morris CD; Cutler JE; Kudenchuk PJ; Peterson JL; Liem LB; Broudy DR; Greene HL; Halperin BD; McAnulty JH
    J Am Coll Cardiol; 1993 Apr; 21(5):1186-92. PubMed ID: 8459075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
    Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
    Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interesting implantable cardioverter defibrillator treatment for lethal ventricular arrhythmias caused by coronary artery spasm: A case report.
    Sun J; Feng L; Li F; Zhang Y; Dong J
    Medicine (Baltimore); 2017 Jun; 96(26):e7251. PubMed ID: 28658116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of nonsustained ventricular tachycardia after revascularization.
    Mittal S; Lomnitz DJ; Mirchandani S; Stein KM; Markowitz SM; Slotwiner DJ; Iwai S; Das MK; Lerman BB
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):342-6. PubMed ID: 12033350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort.
    Weng W; Sapp J; Doucette S; MacIntyre C; Gray C; Gardner M; Abdelwahab A; Parkash R
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1180-1189. PubMed ID: 29759503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.
    Bigger JT
    N Engl J Med; 1997 Nov; 337(22):1569-75. PubMed ID: 9371853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late results with concomitant coronary artery bypass grafting and ICD implantation.
    Lee JH; Konstantakos AK; Murrell HK; Biblo LA; Carlson MD; Mackall JA; Geha AS
    J Card Surg; 1996; 11(3):165-71. PubMed ID: 8889875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic catheter ablation for the prevention of defibrillator therapy.
    Reddy VY; Reynolds MR; Neuzil P; Richardson AW; Taborsky M; Jongnarangsin K; Kralovec S; Sediva L; Ruskin JN; Josephson ME
    N Engl J Med; 2007 Dec; 357(26):2657-65. PubMed ID: 18160685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.